Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FOXO Technologies
West Palm Beach, Florida, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
FOXO Technologies focuses on developing epigenetic technologies to pinpoint biomarkers for human health and aging. It has acquired Myrtle Recovery Centers and Vector Biosource, expanding its capabilities in healthcare services and biospecimen sourcing[1][3].
- Therapeutic areas
- Other
- Modalities
- Epigenetic technologyAI-based epigenetic solutions
- Industry
- Molecular Diagnostics
02
Partnerships
Vector Biosource acquisition
Beyond the preview
Go deeper on FOXO Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FOXO Technologies.